Sign in or Register
- Sign In / Register

Database
Quick Search
News & Analysis
Research
- Quarterly M&A Deals
Bookstore
Events
- Global events calendar

Contact us
Sign-in FAQ
About us
Suggest a story
Subscribe

Sign in

Welcome!Log into your account

your username

your password

Forgot your password?

Password recovery

Recover your password

your email

Search

Contact us
Sign-in FAQ
About us
Suggest a story
Subscribe

Sign in or Register
- Email
  
  Need help signing in?
  
  Issues with signing in? Click here
  
  Don't have an account? Register now

Database
Quick Search
News & Analysis
Research
- Quarterly M&A Deals
Bookstore
Events
- Global events calendar

Home News Briefs KKR commits $60 mln to Slayback Pharma

Return to search

KKR commits $60 mln to Slayback Pharma

Luisa Beltran -

5 January 2017

Create an account to continue reading

Gain instant access to our expert editorial analysis and in-depth insight.

Register for free

Already have an account? Sign in

TAGS
US
VC Deals

Share this

MOST RECENT

EQT to sell Melita to Goldman Sachs Alternatives
Motive Partners’ Rob Heyvaert says ‘fintech too big to ignore’; HIG Capital exits Deenova
15 fintech deals: Private equity capitalizes on AI opportunity

UPCOMING EVENTS

10-12 March
Ritz Carlton, Grande Lakes, Orlando

View all events >

NEWSLETTERS & OPINION

Motive Partners’ Rob Heyvaert says ‘fintech too big to ignore’; HIG Capital exits Deenova
Vistria finding EdTech investment opportunities from pre-K to high school; EY-Parthenon predicts PE deal bump in 2025
Cinven joins PE accountancy push with Grant Thornton UK deal; OTTP, Nordic Capital in for financial advisor

PE DEALS

EQT to sell Melita to Goldman Sachs Alternatives
15 fintech deals: Private equity capitalizes on AI opportunity
Fortress Investment Group acquires industrial manufacturer TH Holdings

Agri Investor
Buyouts
Infrastructure Investor
New Private Markets
PERE
Private Equity International
Private Debt Investor
Private Funds CFO
RCW
Real Estate Capital Europe
PERE Credit
Responsible Investor
Secondaries Investor
Venture Capital Journal

Home
About PE Hub
Contact us
Sign In FAQ
Privacy Notice
Cookie Notice
Terms & Conditions

© PEI Group

Register now

Get limited access to our industry news, analysis and data, plus regular email updates

To register, please review and accept our terms and conditions and privacy notice.

I accept:

Already registered? Click here to login

Sign in to your account

Get limited access to our industry news, analysis and data, plus regular email updates

Don't have an account? Click here to register

Sign in to your account

Email address

Email address not recognised.

Don't have an account? Click here to register

Nearly there!

A verification email is on its way to you. Please check your spam or junk folder just in case.

If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group.

Copyright PEI Media

Not for publication, email or dissemination

Share with other subscribers

Only logged in subscribers of this site will be able to access the shared article.